Avadel Pharmaceuticals SG&A Expense (Quarterly) Insights

Avadel Pharmaceuticals PLC (AVDL)

17.66 -0.43 (-2.38%) USD | NASDAQ | Apr 24, 16:00

17.66 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	41.30M
September 30, 2023	39.16M
June 30, 2023	46.78M
March 31, 2023	24.47M
December 31, 2022	16.98M
September 30, 2022	14.10M
June 30, 2022	21.80M
March 31, 2022	21.64M
December 31, 2021	21.03M
September 30, 2021	21.28M
June 30, 2021	15.17M
March 31, 2021	11.01M
December 31, 2020	8.974M
September 30, 2020	8.423M
June 30, 2020	7.095M
March 31, 2020	7.913M
December 31, 2019	7.663M
September 30, 2019	5.316M
June 30, 2019	6.758M
March 31, 2019	10.45M
December 31, 2018	23.20M
September 30, 2018	24.83M
June 30, 2018	27.84M
March 31, 2018	24.49M
December 31, 2017	23.06M

Date	Value
September 30, 2017	11.56M
June 30, 2017	12.43M
March 31, 2017	11.81M
December 31, 2016	10.69M
September 30, 2016	12.74M
June 30, 2016	11.29M
March 31, 2016	9.461M
December 31, 2015	6.808M
September 30, 2015	4.568M
June 30, 2015	5.873M
March 31, 2015	4.463M
December 31, 2014	3.743M
September 30, 2014	4.105M
June 30, 2014	4.065M
March 31, 2014	3.516M
December 31, 2013	5.094M
September 30, 2013	2.925M
June 30, 2013	2.706M
March 31, 2013	2.491M
December 31, 2012	2.95M
September 30, 2012	3.107M
June 30, 2012	2.913M
March 31, 2012	5.183M
December 31, 2011	3.166M
September 30, 2011	2.59M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.316M

Minimum

Sep 2019

46.78M

Maximum

Jun 2023

18.26M

Average

15.17M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks